Flixotide and Pavtide Accuhalers
Flixotide and Pavtide Accuhalers
Recalling Firm: TGA
Reason for Recall / Hazard
GlaxoSmithKline (GSK) Australia Pty Ltd is issuing a product correction for certain batches of their Flixotide and Pavtide Accuhalers as a small number of Accuhalers may not automatically reload the n...
Product Description & Identification
GlaxoSmithKline (GSK) Australia Pty Ltd is issuing a product correction for certain batches of their Flixotide and Pavtide Accuhalers as a small number of Accuhalers may not automatically reload the next dose.
Affected Products
Flixotide and Pavtide Accuhalers
Additional Source Details
| Field | Value |
|---|---|
| Guid › #text | https://www.tga.gov.au/node/558493 |
| Guid › @ is Perma Link | true |
| Link | https://www.tga.gov.au/safety/recalls-and-other-market-actions/market-actions/flixotide-and-pavtide-accuhalers |
| Pub Date | Wed, 15 Apr 2026 00:00:00 +1000 |
| Extracted category | devices |
Overview
- Recalling FirmTGA
- Risk LevelMedical Device Correction
- DistributionAustralia
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: TGA - Flixotide and Pavtide Accuhalers Check if your household is affected: https://therecallfile.com/recalls/flixotide-and-pavtide-accuhalers/AU-TGA-558493
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.